Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cystic fibrosis–related kidney disease—emerging morbidity and disease modifier

Pediatric Nephrology(2025)10.1007/s00467-025-06715-3Source: DataRank Database

Cystic fibrosis–related kidney disease—emerging morbidity and disease modifier is a research paper published in Pediatric Nephrology (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 2.92)OA: hybridTopics (38)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Manish Kumar ORCID,Himanshu Ballav Goswami ORCID,William T. Harris ORCID,Sladjana Skopelja‐Gardner ORCID,Agnieszka Swiatecka‐Urban ORCID

Live enrichment

PubMed:40095037 PMC:PMC12549735 OpenAlex:https://openalex.org/W4408527661

NHLBI Division of Intramural Research

Grant: R01HL144539

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: P50DK096373-11

Cystic Fibrosis Foundation

Grant: SWIATE24A0-MPI

Cystic Fibrosis Foundation

Grant: SKOPEL24A0-MPI

Cystic Fibrosis Foundation

Grant: HARRIS24A0-MPI

NIDDK

Grant: P20GM130454-04

NIDDK

Grant: P30DK117469

NIDDK NIH HHS

Grant: P50 DK096373

NIGMS NIH HHS

Grant: P20 GM130454

National Institutes of Health

Grant: 1R01HL144539-01

Correcting Pathogenic TGF beta Activity in the Airway

National Institutes of Health

Grant: 2P30DK117469-03

DartCF: The Dartmouth Cystic Fibrosis Research Center

National Institutes of Health

Grant: 2P50DK096373-11

Regulation of Cell Fate during Kidney Development and Disease

National Institutes of Health

Grant: 3P20GM130454-05S2

NOSI cloud computing Supplement

FWCI

2.92

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00467-025-06715-3.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00467-025-06715-3.pdf

publisherhttps://link.springer.com/article/10.1007/s00467-025-06715-3

journalhttps://doi.org/10.1007/s00467-025-06715-3

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40095037

Fields of Study

Cystic Fibrosis Research AdvancesNeonatal Respiratory Health ResearchRenal and related cancers0303 health sciences03 medical and health sciencesHumansCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorRenal Insufficiency, ChronicMutation

MeSH Terms

Cystic FibrosisHumansMutationCystic Fibrosis Transmembrane Conductance RegulatorRenal Insufficiency, Chronic

Keywords

MedicineCystic fibrosisKidney diseaseAcute kidney injuryCystic fibrosis transmembrane conductance regulatorNephrologyPopulationKidneyDiseaseInternal medicineAutosomal dominant polycystic kidney diseaseBioinformaticsPathologyBiologyCftrCkdAkiCfkdHigh-efficiency Modulator TherapyMutationHumansReviewRenal Insufficiency, Chronic

Sustainable Development Goals

SDG 0: Good health and well-being